ARTICLE | Clinical News
Masitinib: Phase III discontinued
September 28, 2015 7:00 AM UTC
AB Science discontinued a double-blind, placebo-controlled, international Phase III trial of masitinib in RA following a futility test conducted by a DSMB. The company said that the test showed the pr...